Skip to main content

Table 2 Percent efficacy of fluralaner based on all live and live-fed Rhipicephalus sanguineus (sensu lato) nymphs from control and treated dogs (Experiment 1). Each group had 10 dogs

From: Evaluation of oral fluralaner (Bravecto®) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato)

Infestation day

Count day

Control

Fluralaner

Efficacy

GM (L)

GM (LF)

GM (L)

GM (LF)

t-value (L)

t-value (LF)

P-value (L)

P-value (LF)

% (L)

% (LF)

− 1

1

37.3

25.6

0.9

0.1

t(18.0) = 12.8

t(18.0) = 26.8

< 0.001

< 0.001

97.7

99.7

2

30.1

29.8

0.1

0.0

t(9.0) = 28.0

t(18.0) = 30.5

< 0.001

< 0.001

99.8

100

6

8

28.1

25.7

1.0

0.0

t(18.0) = 9.0

t(18.0) = 29.9

< 0.001

< 0.001

96.4

100

9

29.7

29.7

0.0

0.0

t(9.0) = 41.0

t(18.0) = 41.0

< 0.001

< 0.001

100

100

28

30

15.5

12.6

2.5

0.0

t(9.0) = 5.8

t(18.0) = 14.7

< 0.001

< 0.001

83.7

100

31

21.4

20.4

0.1

0.0

t(9.0) = 20.4

t(18.0) = 21.9

< 0.001

< 0.001

99.3

100

56

58

13.6

10.0

2.3

0.0

t(9.0) = 6.6

t(18.0) = 13.6

< 0.001

< 0.001

82.9

100

59

21.7

21.6

0.2

0.0

t(9.0) = 18.1

t(18.0) = 23.8

< 0.001

< 0.001

99.1

100

84

86

19.9

16.3

2.6

0.7

t(9.0) = 6.2

t(9.0) = 7.0

< 0.001

< 0.001

86.7

95.7

87

24.7

23.8

0.9

0.6

t(9.0) = 7.5

t(9.0) = 7.5

< 0.001

< 0.001

96.3

97.5

  1. Abbreviations: GM, geometric mean; L, all live (attached and engorged, attached and not engorged, free and engorged, and free and not engorged); LF, live-fed (attached and engorged, attached and not engorged, and free and engorged)